FDA Adverse Event
Malfunction
Summary report: N
ULTEGRA RPFA-TRAP
MDR report key: 302738
·
Received October 26, 2000
Report
- Report Number
- 2031760-2000-00012
- Event Type
- Malfunction
- Date Received
- October 26, 2000
- Date of Event
- September 28, 2000
- Report Date
- October 26, 2000
- Manufacturer
- ACCUMETRICS
- Product Code
- JOZ
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VA, US
- Reporter Occupation
- OTHER
Narratives
Description of Event or Problem · 1
A BLOOD SAMPLE WAS DRAWN FROM A PT TO OBTAIN A BASELINE (PRE-DRUG) PLATELET FUNCTION TEST RESULT USING THE ULTEGRA RPFA-TRAP. A RESULT OF 56 PAU WAS OBTAINED. THIS VALUE IS SIGNIFICANTLY LOWER THAN THE BASELINE REFERENCE RANGE CITED IN THE DEVICE PACKAGE INSERT (125-330 PAU). TEN MINUTES AFTER ADMINISTRATION OF EPTIFIBATIDE ANOTHER BLOOD SAMPLE WAS DRAWN, AND A POST BOLUS TEST RESULT OF 17 PAU WAS OBTAINED. A SECOND ADMINISTRATION (BOLUS) OF EPTIFIBATIDE WAS GIVEN. ANOTHER BLOOD SAMPLE WAS DRAWN TEN MINUTES AFTER THE SECOND BOLUS, AND A RESULT OF 18 PAU WAS OBTAINED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ULTEGRA RPFA-TRAP | PLATELET FUNCTION ASSAY | JOZ | ACCUMETRICS | NA | W12201 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNKNOWN | THE BASELINE SAMPLE WAS DRAWN.| EPTIFIBATIDE (INTEGRILIN) WAS ADMININSTERED AFTER |